We are monitoring the impact of COVID-19 on Point of Care Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1480
Share on
Share on

Global Point of Care Diagnostics Market (POC Testing Market) Size, Share, Trends, COVID-19 Impact and Growth Analysis Report – Segmented By Product, End-User and Region - Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1480
Pages: 165

Global Point of Care Diagnostics Market Size (2021 to 2026)

As per our report, the global point of care (POC) diagnostics market size is estimated to be growing at 9.76% CAGR during the forecast period. The global POC testing market is predicted to grow USD 39.69 billion by 2026 from USD 24.92 billion in 2021.

Point-of-care testing (POCT) is defined as medical diagnostic testing at or near the point of care—that is, at the time and place of patient care. Point-of-care tests are simple medical tests that can be performed at the bedside. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. It increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for better immediate clinical management decisions to be made. The point of care diagnostics, also known as POC testing, is prevalent in enabling test results quickly and accurately. These are user-friendly, where one can take the test by simply following the instructions given on the kit. POC diagnostics have created a decentralized healthcare industry trend, enabling remote patient care, early diagnosis, and cost savings.

The coupling of POCT devices and electronic medical records enables test results to be shared instantly with care providers. The use of mobile devices in the healthcare setting also allows the healthcare provider to access patient test results from a POCT device quickly. A reduction in morbidity and mortality has been associated with such rapid turnaround times from a study using the i-STAT to analyze blood lactate levels after congenital heart surgery.

POCT has become established worldwide and finds vital roles in public health. Potential operational benefits include more rapid decision making and triage, reduced operating times, high-dependency, postoperative care time, emergency room time, number of outpatient clinic visits, number of hospital beds required, ensuring optimal use of professional time, and reduced antimicrobial medication. Tests performed at the point of care allow for a more efficient workflow process. Rapid test results enable expeditious decision-making and treatment. The portable devices are used, which means less space is required, and there’s a lot of flexibility to move workspace.

MARKET DRIVERS:

Immediate test results and growing market penetration of EMR (Electronic Medical Records) and PACS (Picture Archiving and Communication Systems) are potential factors driving the global point of care diagnostics market growth.

Adoption of sedentary lifestyles, unhealthy eating habits, and environmental factors are expected to surge the growth rate of the POC diagnostics market.

Furthermore, the growing demand for more efficient, easy-to-use, and faster consumer devices and these portable personal care devices is fuelling the global POC testing market growth. New product launches of home-testing cancer kits at regular intervals and enhanced laboratories due to the integration of automation techniques in healthcare are estimated to boost the market growth.

Increasing R & D activity to introduce new POC tests and devices for rapid disease detection and monitoring to drive the point of care diagnostics industry progress. Recently in February 2018, Siemens Healthineers gained FDA approval (Food and Drug Administration) for total carbon dioxide (TCO2) and blood urea nitrogen (BUN) POC testing, increasing its market presence.

Also, the high prevalence of chronic illnesses and cancers means that a large customer base deploys cheap and instant diagnostic tests, driving the point-of-care diagnostics/testing market. It is complemented by several cheap initiatives to facilitate POC tests in diagnostic and screening procedures.

MARKET RESTRAINTS:

Lack of skilled people in manufacturing the kits with the latest design in some areas is a major factor restraining the POC testing market demand. Cost is a roadblock factor comparatively, as laboratory testing tends to be less expensive than POC testing. Providers typically require the support of a laboratory to meet quality and accreditation requirements.

Quality assurance can be rigorous testing is performed by clinical staff rather than individuals that have been laboratory-trained. Errors could be arising if the team does not understand the importance of quality control and quality assurance practices.

Impact of COVID-19 on the global POC diagnostics market:

The recent eruption of SARS -CoV-2 posed a significant risk to global health. Due to the lack of vaccine and efficient treatments, many countries have been ruined with an augmenting illness spread with increasing COVID 19 cases. Due to the pandemic crisis, Point-of-Care technologies have quickly pioneered to direct fundamental limitations facing the existing standard diagnostic procedures. The Point-of-care testing market was observed to have a decline during the growth rate. The pharmaceutical and biotechnology companies are employed in COVID 19 point-of-care testing kits for the virus diagnosis. For instance, in July 2020, Becton Dickinson declared about the U.S (FDA) allowed Emergency Use Authorization (EUA) for fast, POC, COVID 19 diagnostic test for use with its extensive availability of BD Veritor Plus System. During the period, the demand and sales for these kits are scheduled to increase the market value.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Product, End-User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This market research report on the Global Point of Care Diagnostics Market (POC Testing Market) has been segmented and sub-segmented based on the product, end-user, and region.

Point of Care Diagnostics Market - By Product:

  • Infectious Diseases
  • Cardiac Markers
  • Oncology Markers
  • OTC Diagnostic Tests
  • Drugs Of Abuse
  • Blood Gas Testing
  • Fertility Testing
  • Urinalysis
  • Coagulation
  • Hematology
  • Glucose Monitoring
  • Ambulatory Chemistry
  • Decentralized Clinical Chemistry

Based on the product, the Glucose monitoring segment leads the market among the products due to factors such as increasing the adoption rate of portable glucose meters with each passing year, growing awareness among diabetic patients to monitor glucose levels in the blood at regular intervals. The cancer markers market segment is to grow at a high pace.

Point of Care Diagnostics Market - By End-User:

Based on end-users, the Clinics segment dominates the market by contributing a significant share to the market every year. It is to grow further during the forecast period due to market boosting factors like availability of portable POC devices, government initiatives, differentiation of healthcare services in different regions, and a rise in the number of CLIA approved testes to diagnose various disorders.

The Home Health care segment is contributing a significant share to the market. It is likely to be growing at a high pace during the forecast period due to the emergence of economical and mobile POC testing devices and increasing demand for POC in home settings. It offers a high level of comfort to the patients.

Point of Care Diagnostics Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Geographically, the North American POC diagnostics market is the market leader in accounting for the highest number of shares in the global POC testing market. In 2020, the North American market was worth USD 8340 Million, and it will continue the growing trends in the years to come. Unhealthy lifestyles, a high number of chronic diseases, a rising number of FDA approvals, and government regulations related to healthcare development are acting as the key drivers behind the growth of POC diagnostics in North America.

The point of care testing market in the Asia Pacific is to grow at a CAGR of 10.2% during the forecast period. In the Asia Pacific, the market is expanding due to the rising prevalence of strategic initiatives taken by international players to improve healthcare infrastructure and increasing awareness in developing countries. In the Asia-pacific region, the market is expanding due to the rising prevalence of strategic initiatives taken by international players to improve healthcare infrastructure.

Europe is the second-largest region with a share of 32% due to the increased adoption of advanced Point of care diagnostic devices, a rise in awareness about innovative and advanced Point of care diagnostic devices.

KEY MARKET PARTICIPANTS:

Notable market participants in the Global Point of Care Diagnostics Market profiled Abbott Laboratories, Inc., Danaher Corporation, Roche Diagnostics Limited, BioMerieux, Siemens Healthcare, Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., and PTS Diagnostics.

Key market players are investing more in R & D to develop innovative products and expand revenues through collaborations with other companies, research universities, and private research organizations.

Siemens Healthineers, one of the leading companies in the POC diagnostics market, presents its customizable products for in vitro diagnostic tests, which are designed to improve workflow, efficiency, and clinical outcomes. The company offers the latest innovations in Central Laboratories' Atellica® solutions, blood gas testing during treatment, and molecular diagnostics. The RAPIDPoint® 500e Blood Gas System2 provides an improved user experience and sets a higher standard for healthcare simplicity, quality, and data security. For labs interested in expanding the reach of molecular diagnostics, the new Fast Track Diagnostics test menu from Siemens Healthineers provides a syndrome panel to improve patient care and workflow.

KEY MARKET HAPPENINGS IN THE RECENT PAST:

1.Introduction                  

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods           

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction              

                2.2 Research Phases      

                                2.2.1 Secondary Research

                                2.2.2 Primary Research

                                2.2.3 Econometric Modelling

                                2.2.4 Expert Validation

                2.3 Analysis Design         

                2.4 Study Timeline          

3. Overview                      

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 Epidemology             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                      

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market

5. Market Segmentation                              

                5.1 Product        

                                5.1.1 Introduction

                                5.1.2 Infectious Diseases

                                5.1.3 Cardiac Markers

                                5.1.4 Oncology Markers

                                5.1.5 OTC Diagnostic Tests

                                5.1.6 Drugs Of Abuse

                                5.1.7 Blood Gas Testing

                                5.1.8 Fertility Testing

                                5.1.9 Urinalysis

                                5.1.10 Coagulation

                                5.1.11 Hematology

                                5.1.12 Glucose Monitoring

                                5.1.13 Ambulatory Chemistry

                                5.1.14 Decentralized Clinical Chemistry

                                5.1.15 Others

                                5.1.16 Y-o-Y Growth Analysis, By Product

                                5.1.17 Market Attractiveness Analysis, By Product

                                5.1.18 Market Share Analysis, By Product

                5.2 End-Users   

                                5.2.1 Introduction

                                5.2.2 Clinics

                                5.2.3 Hospitals

                                5.2.4 Home Healthcare

                                5.2.5 Ambulatory Care Settings

                                5.2.6 Laboratories

                                5.2.7 Others

                                5.2.8 Y-o-Y Growth Analysis, By End-Users

                                5.2.9 Market Attractiveness Analysis, By End-Users

                                5.2.10 Market Share Analysis, By End-Users

                5.3 Mode of Delivery     

                                5.3.1 Introduction

                                5.3.2 OTC

                                5.3.3 Prescription

                                5.3.4 Y-o-Y Growth Analysis, By Mode of Delivery

                                5.3.5 Market Attractiveness Analysis, By Mode of Delivery

                                5.3.6 Market Share Analysis, By Mode of Delivery

6. Geographical Analysis                              

                6.1 Introduction              

                                6.1.1 Regional Trends

                                6.1.2 Impact Analysis

                                6.1.3 Y-o-Y Growth Analysis       

                                6.1.4 Market Attractiveness Analysis

                                6.1.5 Market Share Analysis  

                6.2 North America          

                                6.1.1 Introduction

                                6.1.2 United States

                                6.1.3 Canada 

                6.3 Europe         

                                6.2.1 Introduction

                                6.2.2 U.K

                                6.2.3 Spain

                                6.2.4 Germany

                                6.2.5 Italy 

                                6.2.6 France

                6.4 Asia-Pacific 

                                6.3.1 Introduction

                                6.3.2 China 

                                6.3.3 India 

                                6.3.4 Japan 

                                6.3.5 Australia

                                6.3.6 South Korea

                6.5 Latin America            

                                6.4.1 Introduction

                                6.4.2 Brazil

                                6.4.3 Argentina

                                6.4.4 Mexico

                                6.4.5 Rest of Latin America

                6.6 Middle East & Africa

                                6.5.1 Introduction

                                6.5.2 Middle-East

                                6.5.3 Africa

7.Strategic Analysis                        

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8.Market Leaders' Analysis                          

                8.1 Abbott Laboratories

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Financial analysis

                                8.1.4 Recent Developments

                                8.1.5 SWOT analysis

                                8.1.6 Analyst View

                8.2 Danaher Corporation             

                8.3 Roche Diagnostics    

                8.4 BioMerieux

                8.5 Siemens Healthcare

                8.6 Beckman Coulter     

                8.7 Becton Dickinson and Company        

                8.8 Johnson & Johnson

                8.9 Johnson & Johnson

                8.10 PTS Diagnostics      

9.Competitive Landscape                            

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, collaborations and Joint Ventures          

                9.4 New Product Launches          

10.Market Outlook and Investment Opportunities                           

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Point-of-Care Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  2. Global Point-of-Care Diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
  3. Global Infectious Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  4. Global Cardiac Markers Market, By Region, From 2021 to 2026 (USD Billion)
  5. Global Oncology Markers Market, By Region, From 2021 to 2026 (USD Billion)
  6. Global OTC Diagnostic Tests Market, By Region, From 2021 to 2026 (USD Billion)
  7. Global Drugs Of Abuse Market, By Region, From 2021 to 2026 (USD Billion)
  8. Global Blood Gas Testing Market, By Region, From 2021 to 2026 (USD Billion)
  9. Global Fertility Testing Market, By Region, From 2021 to 2026 (USD Billion)
  10. Global Urinalysis Market, By Region, From 2021 to 2026 (USD Billion)
  11. Global Coagulation Market, By Region, From 2021 to 2026 (USD Billion)
  12. Global Hematology Market, By Region, From 2021 to 2026 (USD Billion)
  13. Global Glucose Monitoring Market, By Region, From 2021 to 2026 (USD Billion)
  14. Global Ambulatory Chemistry Market, By Region, From 2021 to 2026 (USD Billion)
  15. Global Decentralized Clinical Chemistry Market, By Region, From 2021 to 2026 (USD Billion)
  16. Global Others Market, By Region, From 2021 to 2026 (USD Billion)
  17. Global Point-of-Care Diagnostics Market, By End-Users, From 2021 to 2026 (USD Billion)
  18. Global Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  19. Global Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  20. Global Home Healthcare Market, By Region, From 2021 to 2026 (USD Billion)
  21. Global Ambulatory Care Settings Market, By Region, From 2021 to 2026 (USD Billion)
  22. Global Laboratories Market, By Region, From 2021 to 2026 (USD Billion)
  23. Global Others Market, By Region, From 2021 to 2026 (USD Billion)
  24. Global Point-of-Care Diagnostics Market, By Mode of Delivery, From 2021 to 2026 (USD Billion)
  25. Global OTC Market, By Region, From 2021 to 2026 (USD Billion)
  26. Global Prescription Market, By Region, From 2021 to 2026 (USD Billion)
  27. North America Point-of-Care Diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
  28. North America Infectious Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  29. North America Cardiac Markers Market, By Region, From 2021 to 2026 (USD Billion)
  30. North America Oncology Markers Market, By Region, From 2021 to 2026 (USD Billion)
  31. North America OTC Diagnostic Tests Market, By Region, From 2021 to 2026 (USD Billion)
  32. North America Drugs Of Abuse Market, By Region, From 2021 to 2026 (USD Billion)
  33. North America Blood Gas Testing Market, By Region, From 2021 to 2026 (USD Billion)
  34. North America Fertility Testing Market, By Region, From 2021 to 2026 (USD Billion)
  35. North America Urinalysis Market, By Region, From 2021 to 2026 (USD Billion)
  36. North America Coagulation Market, By Region, From 2021 to 2026 (USD Billion)
  37. North America Hematology Market, By Region, From 2021 to 2026 (USD Billion)
  38. North America Glucose Monitoring Market, By Region, From 2021 to 2026 (USD Billion)
  39. North America Ambulatory Chemistry Market, By Region, From 2021 to 2026 (USD Billion)
  40. North America Decentralized Clinical Chemistry Market, By Region, From 2021 to 2026 (USD Billion)
  41. North America Others Market, By Region, From 2021 to 2026 (USD Billion)
  42. North America Point-of-Care Diagnostics Market, By End-Users, From 2021 to 2026 (USD Billion)
  43. North America Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  44. North America Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  45. North America Home Healthcare Market, By Region, From 2021 to 2026 (USD Billion)
  46. North America Ambulatory Care Settings Market, By Region, From 2021 to 2026 (USD Billion)
  47. North America Laboratories Market, By Region, From 2021 to 2026 (USD Billion)
  48. North America Others Market, By Region, From 2021 to 2026 (USD Billion)
  49. North America Point-of-Care Diagnostics Market, By Mode of Delivery, From 2021 to 2026 (USD Billion)
  50. North America OTC Market, By Region, From 2021 to 2026 (USD Billion)
  51. North America Prescription Market, By Region, From 2021 to 2026 (USD Billion)
  52. United States Point-of-Care Diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
  53. United States Point-of-Care Diagnostics Market, By End-Users, From 2021 to 2026 (USD Billion)
  54. United States Point-of-Care Diagnostics Market, By Mode of Delivery, From 2021 to 2026 (USD Billion)
  55. Canada Point-of-Care Diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
  56. Canada Point-of-Care Diagnostics Market, By End-Users, From 2021 to 2026 (USD Billion)
  57. Canada Point-of-Care Diagnostics Market, By Mode of Delivery, From 2021 to 2026 (USD Billion)
  58. Europe Point-of-Care Diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
  59. Europe Infectious Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  60. Europe Cardiac Markers Market, By Region, From 2021 to 2026 (USD Billion)
  61. Europe Oncology Markers Market, By Region, From 2021 to 2026 (USD Billion)
  62. Europe OTC Diagnostic Tests Market, By Region, From 2021 to 2026 (USD Billion)
  63. Europe Drugs Of Abuse Market, By Region, From 2021 to 2026 (USD Billion)
  64. Europe Blood Gas Testing Market, By Region, From 2021 to 2026 (USD Billion)
  65. Europe Fertility Testing Market, By Region, From 2021 to 2026 (USD Billion)
  66. Europe Urinalysis Market, By Region, From 2021 to 2026 (USD Billion)
  67. Europe Coagulation Market, By Region, From 2021 to 2026 (USD Billion)
  68. Europe Hematology Market, By Region, From 2021 to 2026 (USD Billion)
  69. Europe Glucose Monitoring Market, By Region, From 2021 to 2026 (USD Billion)
  70. Europe Ambulatory Chemistry Market, By Region, From 2021 to 2026 (USD Billion)
  71. Europe Decentralized Clinical Chemistry Market, By Region, From 2021 to 2026 (USD Billion)
  72. Europe Others Market, By Region, From 2021 to 2026 (USD Billion)
  73. Europe Point-of-Care Diagnostics Market, By End-Users, From 2021 to 2026 (USD Billion)
  74. Europe Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  75. Europe Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  76. Europe Home Healthcare Market, By Region, From 2021 to 2026 (USD Billion)
  77. Europe Ambulatory Care Settings Market, By Region, From 2021 to 2026 (USD Billion)
  78. Europe Laboratories Market, By Region, From 2021 to 2026 (USD Billion)
  79. Europe Others Market, By Region, From 2021 to 2026 (USD Billion)
  80. Europe Point-of-Care Diagnostics Market, By Mode of Delivery, From 2021 to 2026 (USD Billion)
  81. Europe OTC Market, By Region, From 2021 to 2026 (USD Billion)
  82. Europe Prescription Market, By Region, From 2021 to 2026 (USD Billion)
  83. U.K. Point-of-Care Diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
  84. U.K. Point-of-Care Diagnostics Market, By End-Users, From 2021 to 2026 (USD Billion)
  85. U.K. Point-of-Care Diagnostics Market, By Mode of Delivery, From 2021 to 2026 (USD Billion)
  86. Germany Point-of-Care Diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
  87. Germany Point-of-Care Diagnostics Market, By End-Users, From 2021 to 2026 (USD Billion)
  88. Germany Point-of-Care Diagnostics Market, By Mode of Delivery, From 2021 to 2026 (USD Billion)
  89. France Point-of-Care Diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
  90. France Point-of-Care Diagnostics Market, By End-Users, From 2021 to 2026 (USD Billion)
  91. France Point-of-Care Diagnostics Market, By Mode of Delivery, From 2021 to 2026 (USD Billion)
  92. Italy Point-of-Care Diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
  93. Italy Point-of-Care Diagnostics Market, By End-Users, From 2021 to 2026 (USD Billion)
  94. Italy Point-of-Care Diagnostics Market, By Mode of Delivery, From 2021 to 2026 (USD Billion)
  95. Spain Point-of-Care Diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
  96. Spain Point-of-Care Diagnostics Market, By End-Users, From 2021 to 2026 (USD Billion)
  97. Spain Point-of-Care Diagnostics Market, By Mode of Delivery, From 2021 to 2026 (USD Billion)
  98. Asia-Pacific Point-of-Care Diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
  99. Asia-Pacific Infectious Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  100. Asia-Pacific Cardiac Markers Market, By Region, From 2021 to 2026 (USD Billion)
  101. Asia-Pacific Oncology Markers Market, By Region, From 2021 to 2026 (USD Billion)
  102. Asia-Pacific OTC Diagnostic Tests Market, By Region, From 2021 to 2026 (USD Billion)
  103. Asia-Pacific Drugs Of Abuse Market, By Region, From 2021 to 2026 (USD Billion)
  104. Asia-Pacific Blood Gas Testing Market, By Region, From 2021 to 2026 (USD Billion)
  105. Asia-Pacific Fertility Testing Market, By Region, From 2021 to 2026 (USD Billion)
  106. Asia-Pacific Urinalysis Market, By Region, From 2021 to 2026 (USD Billion)
  107. Asia-Pacific Coagulation Market, By Region, From 2021 to 2026 (USD Billion)
  108. Asia-Pacific Hematology Market, By Region, From 2021 to 2026 (USD Billion)
  109. Asia-Pacific Glucose Monitoring Market, By Region, From 2021 to 2026 (USD Billion)
  110. Asia-Pacific Ambulatory Chemistry Market, By Region, From 2021 to 2026 (USD Billion)
  111. Asia-Pacific Decentralized Clinical Chemistry Market, By Region, From 2021 to 2026 (USD Billion)
  112. Asia-Pacific Others Market, By Region, From 2021 to 2026 (USD Billion)
  113. Asia-Pacific Point-of-Care Diagnostics Market, By End-Users, From 2021 to 2026 (USD Billion)
  114. Asia-Pacific Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  115. Asia-Pacific Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  116. Asia-Pacific Home Healthcare Market, By Region, From 2021 to 2026 (USD Billion)
  117. Asia-Pacific Ambulatory Care Settings Market, By Region, From 2021 to 2026 (USD Billion)
  118. Asia-Pacific Laboratories Market, By Region, From 2021 to 2026 (USD Billion)
  119. Asia-Pacific Others Market, By Region, From 2021 to 2026 (USD Billion)
  120. Asia-Pacific Point-of-Care Diagnostics Market, By Mode of Delivery, From 2021 to 2026 (USD Billion)
  121. Asia-Pacific OTC Market, By Region, From 2021 to 2026 (USD Billion)
  122. Asia-Pacific Prescription Market, By Region, From 2021 to 2026 (USD Billion)
  123. Japan Point-of-Care Diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
  124. Japan Point-of-Care Diagnostics Market, By End-Users, From 2021 to 2026 (USD Billion)
  125. Japan Point-of-Care Diagnostics Market, By Mode of Delivery, From 2021 to 2026 (USD Billion)
  126. China Point-of-Care Diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
  127. China Point-of-Care Diagnostics Market, By End-Users, From 2021 to 2026 (USD Billion)
  128. China Point-of-Care Diagnostics Market, By Mode of Delivery, From 2021 to 2026 (USD Billion)
  129. India Point-of-Care Diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
  130. India Point-of-Care Diagnostics Market, By End-Users, From 2021 to 2026 (USD Billion)
  131. India Point-of-Care Diagnostics Market, By Mode of Delivery, From 2021 to 2026 (USD Billion)
  132. Australia Point-of-Care Diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
  133. Australia Point-of-Care Diagnostics Market, By End-Users, From 2021 to 2026 (USD Billion)
  134. Australia Point-of-Care Diagnostics Market, By Mode of Delivery, From 2021 to 2026 (USD Billion)
  135. South Korea Point-of-Care Diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
  136. South Korea Point-of-Care Diagnostics Market, By End-Users, From 2021 to 2026 (USD Billion)
  137. South Korea Point-of-Care Diagnostics Market, By Mode of Delivery, From 2021 to 2026 (USD Billion)
  138. Latin America Point-of-Care Diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
  139. Latin America Infectious Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  140. Latin America Cardiac Markers Market, By Region, From 2021 to 2026 (USD Billion)
  141. Latin America Oncology Markers Market, By Region, From 2021 to 2026 (USD Billion)
  142. Latin America OTC Diagnostic Tests Market, By Region, From 2021 to 2026 (USD Billion)
  143. Latin America Drugs Of Abuse Market, By Region, From 2021 to 2026 (USD Billion)
  144. Latin America Blood Gas Testing Market, By Region, From 2021 to 2026 (USD Billion)
  145. Latin America Fertility Testing Market, By Region, From 2021 to 2026 (USD Billion)
  146. Latin America Urinalysis Market, By Region, From 2021 to 2026 (USD Billion)
  147. Latin America Coagulation Market, By Region, From 2021 to 2026 (USD Billion)
  148. Latin America Hematology Market, By Region, From 2021 to 2026 (USD Billion)
  149. Latin America Glucose Monitoring Market, By Region, From 2021 to 2026 (USD Billion)
  150. Latin America Ambulatory Chemistry Market, By Region, From 2021 to 2026 (USD Billion)
  151. Latin America Decentralized Clinical Chemistry Market, By Region, From 2021 to 2026 (USD Billion)
  152. Latin America Others Market, By Region, From 2021 to 2026 (USD Billion)
  153. Latin America Point-of-Care Diagnostics Market, By End-Users, From 2021 to 2026 (USD Billion)
  154. Latin America Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  155. Latin America Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  156. Latin America Home Healthcare Market, By Region, From 2021 to 2026 (USD Billion)
  157. Latin America Ambulatory Care Settings Market, By Region, From 2021 to 2026 (USD Billion)
  158. Latin America Laboratories Market, By Region, From 2021 to 2026 (USD Billion)
  159. Latin America Others Market, By Region, From 2021 to 2026 (USD Billion)
  160. Latin America Point-of-Care Diagnostics Market, By Mode of Delivery, From 2021 to 2026 (USD Billion)
  161. Latin America OTC Market, By Region, From 2021 to 2026 (USD Billion)
  162. Latin America Prescription Market, By Region, From 2021 to 2026 (USD Billion)
  163. Brazil Point-of-Care Diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
  164. Brazil Point-of-Care Diagnostics Market, By End-Users, From 2021 to 2026 (USD Billion)
  165. Brazil Point-of-Care Diagnostics Market, By Mode of Delivery, From 2021 to 2026 (USD Billion)
  166. Argentina Point-of-Care Diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
  167. Argentina Point-of-Care Diagnostics Market, By End-Users, From 2021 to 2026 (USD Billion)
  168. Argentina Point-of-Care Diagnostics Market, By Mode of Delivery, From 2021 to 2026 (USD Billion)
  169. Mexico Point-of-Care Diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
  170. Mexico Point-of-Care Diagnostics Market, By End-Users, From 2021 to 2026 (USD Billion)
  171. Mexico Point-of-Care Diagnostics Market, By Mode of Delivery, From 2021 to 2026 (USD Billion)
  172. Rest of Latin America Point-of-Care Diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
  173. Rest of Latin America Point-of-Care Diagnostics Market, By End-Users, From 2021 to 2026 (USD Billion)
  174. Rest of Latin America Point-of-Care Diagnostics Market, By Mode of Delivery, From 2021 to 2026 (USD Billion)
  175. Middle East & Africa Point-of-Care Diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
  176. Middle East & Africa Infectious Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  177. Middle East & Africa Cardiac Markers Market, By Region, From 2021 to 2026 (USD Billion)
  178. Middle East & Africa Oncology Markers Market, By Region, From 2021 to 2026 (USD Billion)
  179. Middle East & Africa OTC Diagnostic Tests Market, By Region, From 2021 to 2026 (USD Billion)
  180. Middle East & Africa Drugs Of Abuse Market, By Region, From 2021 to 2026 (USD Billion)
  181. Middle East & Africa Blood Gas Testing Market, By Region, From 2021 to 2026 (USD Billion)
  182. Middle East & Africa Fertility Testing Market, By Region, From 2021 to 2026 (USD Billion)
  183. Middle East & Africa Urinalysis Market, By Region, From 2021 to 2026 (USD Billion)
  184. Middle East & Africa Coagulation Market, By Region, From 2021 to 2026 (USD Billion)
  185. Middle East & Africa Hematology Market, By Region, From 2021 to 2026 (USD Billion)
  186. Middle East & Africa Glucose Monitoring Market, By Region, From 2021 to 2026 (USD Billion)
  187. Middle East & Africa Ambulatory Chemistry Market, By Region, From 2021 to 2026 (USD Billion)
  188. Middle East & Africa Decentralized Clinical Chemistry Market, By Region, From 2021 to 2026 (USD Billion)
  189. Middle East & Africa Others Market, By Region, From 2021 to 2026 (USD Billion)
  190. Middle East & Africa Point-of-Care Diagnostics Market, By End-Users, From 2021 to 2026 (USD Billion)
  191. Middle East & Africa Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  192. Middle East & Africa Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  193. Middle East & Africa Home Healthcare Market, By Region, From 2021 to 2026 (USD Billion)
  194. Middle East & Africa Ambulatory Care Settings Market, By Region, From 2021 to 2026 (USD Billion)
  195. Middle East & Africa Laboratories Market, By Region, From 2021 to 2026 (USD Billion)
  196. Middle East & Africa Others Market, By Region, From 2021 to 2026 (USD Billion)
  197. Middle East & Africa Point-of-Care Diagnostics Market, By Mode of Delivery, From 2021 to 2026 (USD Billion)
  198. Middle East & Africa OTC Market, By Region, From 2021 to 2026 (USD Billion)
  199. Middle East & Africa Prescription Market, By Region, From 2021 to 2026 (USD Billion)
  200. Middle East Point-of-Care Diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
  201. Middle East Point-of-Care Diagnostics Market, By End-Users, From 2021 to 2026 (USD Billion)
  202. Middle East Point-of-Care Diagnostics Market, By Mode of Delivery, From 2021 to 2026 (USD Billion)
  203. Africa Point-of-Care Diagnostics Market, By Application, From 2021 to 2026 (USD Billion)
  204. Africa Point-of-Care Diagnostics Market, By End-Users, From 2021 to 2026 (USD Billion)
  205. Africa Point-of-Care Diagnostics Market, By Mode of Delivery, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample